|
Status |
Public on Dec 11, 2015 |
Title |
Human MCF-7 cells treated with MELK-T1 during 72 hours 16022 |
Sample type |
RNA |
|
|
Source name |
MCF-7
|
Organism |
Homo sapiens |
Characteristics |
cell line: MCF-7 treatment: MELK-T1 time (hours): 72
|
Treatment protocol |
MCF-7 cells were incubated with 10 µM of MELK-T1 for 48 h. DMSO was used as negative control.
|
Growth protocol |
MCF-7 cells were cultured in high-glucose DMEM (LifeTechnologies) supplemented with 10% FBS (LifeTechnologies).
|
Extracted molecule |
total RNA |
Extraction protocol |
Cells were lysed using RLT buffer (Qiagen) and RNA extracted with the RNeasy 96 kit (p/n 74181 Qiagen).
|
Label |
biotin
|
Label protocol |
All microarray related steps for target preparation including amplification of total RNA and labeling were carried out as described in the GeneChip®3’ IVT, Express Kit User Manual , (Affymetrix 2004).
|
|
|
Hybridization protocol |
Target hybridization was processed on the GeneTitan® Instrument according to the instructions provided in the User Guide for Expression Array Plates (P/N 702933).
|
Scan protocol |
Plate scan was processed on the GeneTitan® Instrument according to the instructions provided in the User Guide for Expression Array Plates (P/N 702933). Images were analyzed using the GeneChip® Command Console Software (AGCC), (Affymetrix).
|
Data processing |
The data were analyzed with R version 3.0.1 using RMA algorithm for preprocessing (affy_1.38.1) and Entrez based alternative CDF version 15.1.0 for probeset annotation
|
|
|
Submission date |
Oct 18, 2014 |
Last update date |
Dec 11, 2015 |
Contact name |
Steven Osselaer |
E-mail(s) |
sosselae@its.jnj.com
|
Organization name |
Janssen Pharmaceutica NV
|
Street address |
Turnhoutseweg 30
|
City |
Beerse |
ZIP/Postal code |
2340 |
Country |
Belgium |
|
|
Platform ID |
GPL19309 |
Series (1) |
GSE62477 |
MELK-T1, a small molecule inhibitor of protein kinase MELK, decreases DNA damage tolerance in highly proliferating cancer cells |
|